Overview

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

Status:
Recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
This trial studies how well positron emission tomography/magnetic resonance imaging (PET/MRI) scan works in checking patients with stage IA1-IB3 cervical cancer that can be removed by surgery (resectable). PET/MRI scan may help doctors learn more about the spread of the disease.
Phase:
Early Phase 1
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
National Cancer Institute (NCI)
Treatments:
Deoxyglucose
Fluorodeoxyglucose F18